Glycosylated Hemoglobin, Cardiovascular, and Renal Outcomes in a Pharmacist-Managed Clinic

Cioffi, Seth T.; Caron, Michael F.; Kalus, James S.; Hill, P G; Buckley, Thomas E.

doi:10.1345/aph.1d359

Cited by 56 publications

(46 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[3][4][5][6][7] The current study assessed A1C changes resulting from seeing a pharmacist and then compared them to changes that result from usual care to find out whether pharmacist care results in any additional benefit.…”

mentioning

confidence: 99%

Impact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting

Stading¹,

Herrmann²,

Walters³

et al. 2009

Diabetes Spectrum

View full text Add to dashboard Cite

mentioning

confidence: 99%

Impact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting

Stading¹,

Herrmann²,

Walters³

et al. 2009

Diabetes Spectrum

View full text Add to dashboard Cite

“…Dispensing of test strips provides an opportunity to support the patient with the complicated process of SMBG. Furthermore, pharmacist-led intervention programs, including education and training of SMBG skills, showed a decrease in HbA1c-values attributed to the pharmaceutical care services [26][27][28][29][30]. Moreover, because of the observed differences between pharmacies, not all may experience the same barriers in dispensing of test strips.…”

Section: Discussionmentioning

confidence: 99%

Regional Influences on the Dispensing of Glucose Test Strips in Dutch Community Pharmacies

et al. 2006

View full text Add to dashboard Cite

Background: Pharmacy practice guidelines promote the role of community pharmacies in selfmonitoring of blood glucose. However, variations between Dutch pharmacies exist in the proportion of patients to whom test strips are dispensed. Objective: To assess whether variations between community pharmacies in dispensing of blood glucose test strips can be explained by differences in patient characteristics and the region in which the pharmacy is located. Setting: PHARMO-Record Linkage System containing drug dispensing histories from 40 community pharmacies of about 450,000 patients in the Netherlands. Method: We performed a retrospective cohort study. Data on prescription of all drugs and medical aids between 1991 and 2001 were extracted for all new users of antidiabetic drugs. Patients were excluded if the dispensing history did not allow classification of the type of diabetes or if the dispensing pharmacy could not be determined. The data were analysed using a Cox proportional hazard model. Main outcome measure: Time to first test strips dispensed. Results: We identified 8,233 starters of antidiabetic drugs. During a median follow-up of 2.1 years, 20% of the patients were dispensed test strips at least once. Community pharmacy was significantly associated with the dispensing of test strips after adjustment for patient characteristics. This association was less apparent when stratified for the geographical location of the pharmacy. Conclusion: Community pharmacy is an independent determinant of the start of use of test strips. Differences in dispensing of test strips between pharmacies are dependent on geographical region. This suggests that implementing practice guidelines for diabetes care in community pharmacy requires different approaches in different regions.

show abstract

“…The pharmacist-run group showed a better improvement in A1c outcome, compared to the standard care. 54 A study demonstrated by Cioffi et al, (2004) reported that, clinical pharmacist can effectively care for diabetes patients referred by their primary care provider because of poor glycemic control. a better achieving in HbA1c, BP and LDL values was obtained in the pharmacistmanaged group compared with other healthcare professionals, which indicates diabetes patients managed by pharmacist had a significant reduction in HbA1c.…”

Section: Effect On Glycated Hemoglobin A1c (Hba1c) Bp and Lipid Profmentioning

confidence: 99%

The Current Scenario of Clinical Pharmacy Service in the Management of Patients with Diabetes Mellitus and Related Complications: Review Article

Demoz¹,

Gebremariam²,

Legesse³

2018

IJOPP

View full text Add to dashboard Cite

Diabetes Mellitus (DM) is a group of metabolic disorder characterized by defect in insulin secretion, insulin action or both. The prevalence of diabetes continues to rise worldwide, placed in an increasing burden on healthcare systems and for the individual payers. This review is aimed to organize and examines the contribution of pharmacist in people living with diabetes mellitus and reviewed to whether the extent of diabetes management interventions delivered by pharmacist is successful in achieving the goal of therapy in DM patients. Many studies revealed and confirmed that the positive impacts of pharmacists intervention on monitoring of blood glucose level, blood pressure, lipid profiles, body mass indexes, diabetes related complications, economic benefits, improving health related quality of life, drug-related problems, adherence to medication, provision of patient education and counseling services, medication therapy management services and other pharmaceutical care services that enhance the clinical outcomes in diabetes patients were better than the usual care services. In all cases, it was proven that the intervention was successful in achieving the goals of therapy in diabetes patients and reducing other complications associated with the disease. Therefore, pharmacist integration into a health care team had shown to be effective in improving a number of clinical health outcomes in diabetic patients. This may be helpful to realize the current progress of pharmacist'srole in people living with diabetes and associated complications.

show abstract

Glycosylated Hemoglobin, Cardiovascular, and Renal Outcomes in a Pharmacist-Managed Clinic

Abstract: This study demonstrated that a clinical pharmacist can effectively care for patients with diabetes referred by their primary care provider because of poor glycemic control.

Cited by 56 publications

References 13 publications

Impact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting

Impact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting

Regional Influences on the Dispensing of Glucose Test Strips in Dutch Community Pharmacies

The Current Scenario of Clinical Pharmacy Service in the Management of Patients with Diabetes Mellitus and Related Complications: Review Article

Contact Info

Product

Resources

About